A new marketing study has indicated a high level of patient satisfaction following lip enhancements.
The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.
Hyaluronic acid dermal filler Restylane Kysse has been approved by the US Food and Drug Administration (FDA) for lip augmentation and the correction of upper perioral rhytids.
Pharmaceutical company Galderma hosted their Inaugural GAIN (Galderma Aesthetic Injector Network) event in Geneva, Switzerland, highlighting what transformational aesthetic journeys look like for different patients.
Pharmaceutical company Galderma will be hosting a free, two-hour webinar on the Aesthetics Media website between 7-9pm on March 11.
Medical aesthetic company Intraline has released three new dermal fillers to its M Series line, the M2 Plus, the M3 Plus and M4 Plus.
Pharmaceutical company Galderma has launched hyaluronic acid filler Restylane Eyelight to the UK.
Pharmaceutical company Galderma is discontinuing the Restylane Fynesse dermal filler from the Optimal Balance Technology (OBT) range.
Pharmaceutical company Sinclair held a Power Brunch in London to investigate the topic of women’s experiences with judgements on appearance.
World-renowned plastic surgeon and aesthetic practitioner Dr Arthur Swift has announced a training day in London this month, in collaboration with Prollenium.